Integrin Alpha 4 - Integrin Alpha 4 is a protein encoded by ITGA4. Integrins alpha-4 (VLA-4) subunit associates with a beta 1 or beta-7 subunit to form an integrin that plays a role in cell motility and migration.
This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease and inflammatory bowel disease. They are receptors for fibronectin.
They recognize one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin.
They are also receptors for VCAM1.
Report Source: www.themarketreports.com/report/in…e-review-h1-2018
Reasons to access
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Integrin Alpha 4
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Integrin Alpha 4 development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Report available at: www.themarketreports.com/report/buy-now/941755
- Amgen Inc
- Antisense Therapeutics Ltd
- Biogen Inc
- BioMAS Ltd
- Daiichi Sankyo Co Ltd
- EA Pharma Co Ltd
- Immunwork Inc
- Morphic Therapeutic Inc
- Protagonist Therapeutics Inc
- Takeda Pharmaceutical Co Ltd
- Viriom Inc
Got a question; ask us at: www.themarketreports.com/report/ask-your-query/941755
Category: Market Research Publishers and RetailersCompany about: The Market Reports aims to provide the best industry and market reports to a seeker. We are looking forward to a place where we are the one stop destination for all the report seekers irrespective of any country, category, domain, etc. We are always open on call and email (24*7) to your queries and very clean with the business methodology. Since we are dealing with so many Publishers, we can actually give you what suits best in accordance to your requirements.
For more information: